ICON's AI-directed video engine cuts clinical trial video production time by 90%, streamlining site selection and training ...
Citius Oncology presents LYMPHIR quality-of-life data from pivotal Study 302 at EORTC meeting, supporting formulary ...
Eton's ET-700 shows better tolerability than GALZIN but reduced efficacy in Wilson disease pilot study with 12 patients per ...
Ivonescimab perioperative NSCLC study shows 50.7% pathological complete response rate, outpacing current standard-of-care ...
BRII-179 showed 32% HBsAg loss durability at 24 weeks post-treatment in the Phase 2b ENRICH study, with consistent results ...
ATG-201 Phase I trial opens in China for B cell autoimmune diseases, testing a CD19×CD3 bispecific with masking technology to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results